Glucans as new anticancer agents

23Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

For decades, glucans have been studied for their biological and immunological activities. The scientific community has mainly focused on immune reactions, but other areas, such as cholesterol levels and diabetic retinopathy, have shown the positive effects of glucan supplementation. However, the majority of studies focused on possible cancer suppression, where glucans showed clear and significant effects on numerous types of cancers, leading not only to clinical trials, but to approval as an official drug. The aim of this review is to describe the current knowledge of this field.

Cite

CITATION STYLE

APA

Sima, P., Richter, J., & Vetvicka, V. (2019). Glucans as new anticancer agents. Anticancer Research. International Institute of Anticancer Research. https://doi.org/10.21873/anticanres.13480

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free